Home

America's Next Top Value Stock

28.05.10

Will bid adieu to its patents on Cozaar and Hyzaar this year, and will do the same with Singulair in 2012. Cozaar and Hyzaar combined for $3.6 billion in gross income in 2009, while Singulair pulled in $4.7 billion.

But as my fellow Fool Brian Orelli peaked out recently , the pharma folks aren't taking this sitting down. Instead, they're investing big kale in drug trials that could pay off with huge, new blockbuster drugs. Though Brian also noted that Pfizer in peculiar has had some high-profile blowups when it comes to these big trials, CAPS members seem convinced that the society's history of success and healthy cash reserves will help its stock outrun the be placed of the market.

But even with a strong four-star rating, Pfizer didn't have enough to beat out this week's top value stock: Eagle Mass Shipping .

Though CAPS members have shied away from fellow shipper DryShips, they've flocked to Eagle Largeness Shipping. And if you're looking for an aggressive way to play the global economic recovery, Eagle Volume Shipping may be exactly what you're looking for.

Source: Motley Fool